Mitochondrial fragmentation is crucial for <i>c</i>-<i>Myc</i>-driven hepatoblastoma-like liver tumors

Dalin Wang,Jiming Tian,Zeyu Yan,Qing Yuan,Dan Wu,Xiaoli Liu,Shirong Yang,Shanshan Guo,Jianxun Wang,Yongxiu Yang,Jinliang Xing,Jiaze An,Qichao Huang

DOI: https://doi.org/10.1016/j.ymthe.2022.01.032

2022-01-01

Abstract:Hepatoblastoma is the most common liver cancer in children, and the aggressive subtype often has a poor prognosis and lacks effective targeted therapy. Although aggressive hepatoblastoma (HB) is often accompanied by abnormally high expression of the transcription factor c-Myc, the underlying mechanism remains unclear. In this study, we found that mitochondrial fragmentation was enhanced by c-Myc overexpression in human aggressive HB tissues and was associated with poor prognosis. Then, a mouse model resembling human HB was established via hydrodynamic injection of c-Myc plasmids. We observed that liverspecific knockout of the mitochondrial fusion molecule MFNI or overexpression of mitochondrial fission molecule DRP1 promoted the occurrence of c-Myc-driven liver cancer. In contrast, when MFNI was overexpressed in the liver, tumor formation was delayed. In vitro experiments showed that c-Myc transcriptionally upregulated the expression of DRP1 and decreased MFNI expression through upregulation of miR-373-3p. Moreover, enhanced mitochondrial fragmentation significantly promoted aerobic glycolysis and the proliferation of HB cells by significantly increasing reactive oxygen species (ROS) production and activating the RAC-alpha serine/threonine-protein kinase (AKT)/mammalian target of rapamycin (mTOR) and nuclear factor kappa B (NF-kappa B) pathways. Taken together, our results indicate that c-Myc-mediated mitochondrial fragmentation promotes the malignant transformation and progression of HB by activating ROS-mediated multi-oncogenic signaling.